Showing results (11-20 of 30) with videos related to
Sort By:
Pageof 3
Breast Cancer Research and Treatment|July 29, 2010
Bilateral breast cancer: analysis of incidence, outcome, survival and disease characteristicsElrasheid A H Kheirelseid, Hanzali Jumustafa, Nicola Miller, et al.BMC Cancer|August 30, 2011
Younger age as a prognostic indicator in breast cancer: a cohort studyElrasheid H A Kheirelseid, Jennifer M E Boggs, Catherine Curran, et al.Breast Cancer Research and Treatment|April 25, 2009
The TGFBR1*6A/9A polymorphism is not associated with differential risk of breast cancerGabrielle Colleran, Niall McInerney, Andrew Rowan, et al.Irish Journal of Medical Science|July 23, 2018
The changing cost of breast cancer care: lessons from a centralised modern cancer centreDoireann P Joyce, Ciaran O'Neill, Helen M Heneghan, et al.Breast Cancer Research and Treatment|April 6, 2017
Differential impact of hormone receptor status on survival and recurrence for HER2 receptor-positive breast cancers treated with TrastuzumabAndrew McGuire, Olga Kalinina, Emma Holian, et al.Plos One|July 23, 2013
miR-379 regulates cyclin B1 expression and is decreased in breast cancerSonja Khan, Cathy L Brougham, James Ryan, et al.International Journal of Colorectal Disease|August 21, 2012
miRNA expressions in rectal cancer as predictors of response to neoadjuvant chemoradiation therapyElrasheid A H Kheirelseid, Nicola Miller, Kah Hoong Chang, et al.Breast Cancer Research and Treatment|November 14, 2008
Low penetrance breast cancer predisposition SNPs are site specificNiall Mcinerney, Gabrielle Colleran, Andrew Rowan, et al.The Oncologist|March 16, 2022
Longitudinal Evaluation of Circulating Tumor DNA Using Sensitive Amplicon-Based Next-Generation Sequencing to Identify Resistance Mechanisms to Immune Checkpoint Inhibitors for Advanced Urothelial CarcinomaPraful Ravi, Arvind Ravi, Irbaz B Riaz, et al.Journal for Immunotherapy of Cancer|April 3, 2020
Conditional immune toxicity rate in patients with metastatic renal and urothelial cancer treated with immune checkpoint inhibitorsPier Vitale Nuzzo, Gregory R Pond, Sarah Abou Alaiwi, et al.Pageof 3